• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

食管癌根治性切除术后阴性淋巴结的意义:一项回顾性队列研究

The Significance of Negative Lymph Nodes in Esophageal Cancer After Curative Resection: A Retrospective Cohort Study.

作者信息

Mo Junxian, Chen Dongni, Li Changbo, Chen Mingwu

机构信息

Department of Cardio-Thoracic Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, People's Republic of China.

Department of Cardio-Thoracic Surgery, The Seventh Affiliated Hospital of Guangxi Medical University, Wuzhou, Guangxi 543000, People's Republic of China.

出版信息

Cancer Manag Res. 2020 Feb 20;12:1269-1279. doi: 10.2147/CMAR.S232856. eCollection 2020.

DOI:10.2147/CMAR.S232856
PMID:32110101
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7039082/
Abstract

OBJECTIVE

The impact of negative lymph nodes (NLNs) count on prognosis in esophageal cancer (EC) was analyzed using two institutions surgical database.

METHODS

We conducted a retrospective study of 768 EC patients treated by surgical resection between January 2010 and December 2012. The effects of the NLNs count on prognosis was analyzed. Cox regression model was conducted to determine the significant prognostic elements.

RESULTS

The number of NLNs was studied as a categorical variable based on the quartiles (Q1: ≤15, Q2: 16-21, Q3: 22-30, Q4: ≥31). And a better overall survival (OS) was observed with increasing number of NLNs (HR= 0.762; 95% CI, 0.596-0.974 for Q2, HR= 0.666; 95% CI, 0.516-0.860 for Q3 and HR= 0.588; 95% CI, 0.450-0.768 for Q4) (all <0.05). Multivariate regression analysis revealed that the NLNs count was an independent prognostic factor. Besides, for patients in T2 or T3 stage, a high number of NLNs was found to be significantly associated with a favorable OS (log rank <0.001).

CONCLUSION

A higher number of NLNs is independently related to the better OS in EC patients after surgical resection.

摘要

目的

利用两个机构的手术数据库分析阴性淋巴结(NLNs)数量对食管癌(EC)预后的影响。

方法

我们对2010年1月至2012年12月期间接受手术切除的768例EC患者进行了回顾性研究。分析了NLNs数量对预后的影响。采用Cox回归模型确定显著的预后因素。

结果

根据四分位数将NLNs数量作为分类变量进行研究(Q1:≤15,Q2:16 - 21,Q3:22 - 30,Q4:≥31)。随着NLNs数量增加,总生存期(OS)更佳(Q2的HR = 0.762;95%CI,0.596 - 0.974,Q3的HR = 0.666;95%CI,0.516 - 0.860,Q4的HR = 0.588;95%CI,0.450 - 0.768)(均<0.05)。多因素回归分析显示NLNs数量是独立的预后因素。此外,对于T2或T3期患者,发现大量NLNs与良好的OS显著相关(对数秩<0.001)。

结论

手术切除后,EC患者中较高数量的NLNs与较好的OS独立相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c2e/7039082/96d0bdfb2afc/CMAR-12-1269-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c2e/7039082/96d0bdfb2afc/CMAR-12-1269-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c2e/7039082/96d0bdfb2afc/CMAR-12-1269-g0002.jpg

相似文献

1
The Significance of Negative Lymph Nodes in Esophageal Cancer After Curative Resection: A Retrospective Cohort Study.食管癌根治性切除术后阴性淋巴结的意义:一项回顾性队列研究
Cancer Manag Res. 2020 Feb 20;12:1269-1279. doi: 10.2147/CMAR.S232856. eCollection 2020.
2
Number of negative lymph nodes should be considered for incorporation into staging for breast cancer.应考虑将阴性淋巴结数量纳入乳腺癌分期。
Am J Cancer Res. 2015 Jan 15;5(2):844-53. eCollection 2015.
3
The Prognostic Value of the Number of Negative Lymph Nodes Combined with Positive Lymph Nodes in Esophageal Cancer Patients: A Propensity-Matched Analysis.淋巴结阴性数目与阳性淋巴结数目联合预测食管癌患者预后的价值:倾向评分匹配分析。
Ann Surg Oncol. 2020 Jun;27(6):2042-2050. doi: 10.1245/s10434-019-08083-3. Epub 2020 Jan 2.
4
Number of negative lymph nodes can predict survival of breast cancer patients with four or more positive lymph nodes after postmastectomy radiotherapy.阴性淋巴结数量可预测乳房切除术后放疗后有四个或更多阳性淋巴结的乳腺癌患者的生存情况。
Radiat Oncol. 2014 Dec 16;9:284. doi: 10.1186/s13014-014-0284-5.
5
Number of negative lymph nodes as a prognostic factor in esophageal squamous cell carcinoma.阴性淋巴结数量作为食管鳞状细胞癌的一个预后因素
Asia Pac J Clin Oncol. 2017 Oct;13(5):e278-e283. doi: 10.1111/ajco.12567. Epub 2016 Aug 4.
6
Number of negative lymph nodes as a prognostic factor for ypN0-N1 breast cancer patients undergoing neoadjuvant chemotherapy.阴性淋巴结数量作为接受新辅助化疗的ypN0-N1期乳腺癌患者的预后因素
Tumour Biol. 2016 Jun;37(6):8445-54. doi: 10.1007/s13277-015-4640-3. Epub 2016 Jan 5.
7
Critical prognostic value of the log odds of negative lymph nodes/tumor size in rectal cancer patients.直肠癌患者阴性淋巴结对数比/肿瘤大小的关键预后价值。
World J Clin Cases. 2021 May 26;9(15):3531-3545. doi: 10.12998/wjcc.v9.i15.3531.
8
Number of negative lymph nodes is associated with disease-free survival in patients with breast cancer.阴性淋巴结数量与乳腺癌患者的无病生存期相关。
BMC Cancer. 2015 Feb 7;15:43. doi: 10.1186/s12885-015-1061-z.
9
Number of negative lymph nodes can predict survival after postmastectomy radiotherapy according to different breast cancer subtypes.根据不同的乳腺癌亚型,阴性淋巴结数量可预测乳房切除术后放疗后的生存率。
J Cancer. 2015 Jan 20;6(3):261-9. doi: 10.7150/jca.10402. eCollection 2015.
10
The Number of Negative Lymph Nodes is Positively Associated with Survival in Esophageal Squamous Cell Carcinoma Patients in China.在中国,食管鳞状细胞癌患者的阴性淋巴结数量与生存率呈正相关。
Open Med (Wars). 2020 Mar 8;15:152-159. doi: 10.1515/med-2020-0023. eCollection 2020.

引用本文的文献

1
Prognostic value of the log odds of negative lymph nodes/T stage ratio (LONT) in postoperative esophageal cancer: a SEER-based study.阴性淋巴结/肿瘤分期比值(LONT)的对数优势比在食管癌术后的预后价值:一项基于监测、流行病学和最终结果(SEER)数据库的研究
Front Oncol. 2025 Aug 20;15:1619106. doi: 10.3389/fonc.2025.1619106. eCollection 2025.
2
Negative lymph node count is an independent prognostic factor for female patients with node positive breast cancer.阴性淋巴结计数是女性淋巴结阳性乳腺癌患者的独立预后因素。
Transl Cancer Res. 2020 Dec;9(12):7450-7457. doi: 10.21037/tcr-20-2351.
3
The role of multiple metabolic genes in predicting the overall survival of colorectal cancer: A study based on TCGA and GEO databases.

本文引用的文献

1
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
2
The STROCSS statement: Strengthening the Reporting of Cohort Studies in Surgery.STROCSS 声明:加强外科学队列研究报告。
Int J Surg. 2017 Oct;46:198-202. doi: 10.1016/j.ijsu.2017.08.586. Epub 2017 Sep 7.
3
Recommendations for pathologic staging (pTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals.
多代谢基因在预测结直肠癌总生存期中的作用:基于 TCGA 和 GEO 数据库的研究。
PLoS One. 2021 Aug 16;16(8):e0251323. doi: 10.1371/journal.pone.0251323. eCollection 2021.
4
Optimal Range of Lymphadenectomy in Pathological Stage T1 and T2 Esophageal Squamous Cell Carcinoma.病理分期为T1和T2的食管鳞状细胞癌淋巴结清扫的最佳范围
Front Oncol. 2021 May 25;11:619556. doi: 10.3389/fonc.2021.619556. eCollection 2021.
5
The Number of Harvested LNs Is an Independent Prognostic Factor in Lymph Node Metastasis-negative Patients Who Received Curative Esophagectomy.清扫的淋巴结数目是接受根治性食管切除术且淋巴结转移阴性患者的独立预后因素。
In Vivo. 2020 Jul-Aug;34(4):2021-2027. doi: 10.21873/invivo.12001.
第8版美国癌症联合委员会(AJCC)/国际抗癌联盟(UICC)分期手册中食管癌和食管胃交界癌的病理分期(pTNM)推荐
Dis Esophagus. 2016 Nov;29(8):897-905. doi: 10.1111/dote.12533.
4
Recommendations for neoadjuvant pathologic staging (ypTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals.《美国癌症联合委员会(AJCC)/国际抗癌联盟(UICC)第8版分期手册中食管癌和食管胃交界癌新辅助病理分期(ypTNM)的推荐》
Dis Esophagus. 2016 Nov;29(8):906-912. doi: 10.1111/dote.12538.
5
Prognosis of patients with esophageal squamous cell carcinoma after esophagectomy using the log odds of positive lymph nodes.使用阳性淋巴结的对数优势比评估食管鳞状细胞癌患者食管切除术后的预后。
Oncotarget. 2015 Nov 3;6(34):36911-22. doi: 10.18632/oncotarget.5366.
6
Extent of lymph node removal during esophageal cancer surgery and survival.食管癌手术中淋巴结清扫的范围与生存。
J Natl Cancer Inst. 2015 Mar 5;107(5). doi: 10.1093/jnci/djv043. Print 2015 May.
7
Global cancer statistics, 2012.全球癌症统计数据,2012 年。
CA Cancer J Clin. 2015 Mar;65(2):87-108. doi: 10.3322/caac.21262. Epub 2015 Feb 4.
8
Comparison of Ivor-Lewis vs Sweet esophagectomy for esophageal squamous cell carcinoma: a randomized clinical trial.Ivor-Lewis 与 Sweet 食管癌切除术治疗食管鳞癌的比较:一项随机临床试验。
JAMA Surg. 2015 Apr;150(4):292-8. doi: 10.1001/jamasurg.2014.2877.
9
Prognostic value of different lymph node staging methods in esophageal squamous cell carcinoma after esophagectomy.不同淋巴结分期方法对食管鳞状细胞癌食管切除术后的预后价值
Ann Thorac Surg. 2015 Jan;99(1):284-90. doi: 10.1016/j.athoracsur.2014.08.036. Epub 2014 Nov 18.
10
Can lymph node ratio replace pn categories in the tumor-node-metastasis classification system for esophageal cancer?淋巴结比率能否替代食管癌肿瘤-淋巴结-转移分期系统中的 pn 分类?
J Thorac Oncol. 2014 Aug;9(8):1214-21. doi: 10.1097/JTO.0000000000000216.